Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 189,485	$ 128,451
Short-term investments (note 5)	298,179	170,453
Accounts receivable	8,653	2,185
Prepaid expenses and other current assets	8,291	10,741
Total current assets	504,608	311,830
Deferred financing fees	590	650
Long-term investments (note 5)	75,758	0
Long-term prepaid assets	2,277	2,306
Deferred tax asset	459	1,218
Property and equipment, net	11,032	11,100
Operating lease right-of-use assets	6,320	5,400
Intangible assets, net	5,890	6,057
Acquired in-process research and development (note 6)	17,628	17,628
Goodwill (note 6)	12,016	12,016
Total assets	636,578	368,205
Current liabilities:
Accounts payable and accrued liabilities (note 7)	37,234	35,691
Fair value of liability classified options (note 12)	33,899	45,569
Current portion of operating lease liability (note 11)	1,749	1,282
Other current liabilities	23	10
Total current liabilities	72,905	82,552
Long-term portion of operating lease liability (note 11)	7,258	5,599
Long-term portion of deferred revenue (note 9)	32,941	32,941
Other long-term liabilities (note 7)	1,055	1,024
Deferred tax liability	0	408
Total liabilities	114,159	122,524
Shareholders’ equity:
Common shares, no par value; unlimited authorized shares at March 31, 2020 and December 31, 2019, respectively; 45,533,201 and 39,564,529 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively (note 8b)	707,610	450,210
Additional paid-in capital	143,313	92,839
Accumulated other comprehensive loss	(6,659)	(6,659)
Accumulated deficit	(321,845)	(290,709)
Total shareholders’ equity	522,419	245,681
Total liabilities and shareholders’ equity	636,578	368,205
Commitments and contingencies (note 13)